All lobbying filings
Ballard Partners
Ballard Partners filed a Q3 report for Novavax, Inc. on October 16, 2025, reporting $50,000 in lobbying income.
Lobbying for Novavax, Inc. · Biotechnology company
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 16, 2025
Income
$50,000
What the client paid this registrant for the period.
Client based in
Maryland
Lobbyists on this filing
1
-
JEFF MILLER Former member of CongressPreviously held: Former Member US Congress
Government bodies contacted
4
Lobbying activity
1
Guidance navigating vaccine policy.